← back to search

Adriane Hommertgen

Heidelberg University · DE
🔎 Find collaborators in Radiation · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Radiation · Pulmonary and Respiratory Medicine
Research interest
Research interests include Advanced Radiotherapy Techniques, Cancer Immunotherapy and Biomarkers, Radiation Therapy and Dosimetry, and Head and Neck Cancer Studies.
h-index
11
citations
296
works
24
NIH funding
primary concept
email

Recent publications

Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial
BMC Cancer 2022cited by 6position: middledoi
Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial
Radiotherapy and Oncology 2021cited by 17position: middledoi
Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial
Trials 2021cited by 15position: middledoi
3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial
Radiation Oncology 2021cited by 12position: middledoi
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial)
International Journal of Radiation Oncology*Biology*Physics 2020cited by 59position: middledoi
Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study
BMC Cancer 2020cited by 20position: middledoi
Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial
Radiation Oncology 2020cited by 15position: middledoi
Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial
Trials 2020cited by 13position: middledoi
Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial
BMC Cancer 2020cited by 13position: middledoi
Durvalumab in frail and elder patients with stage four NSCLC: Study protocol of the randomized phase II DURATION trial
Research Square 2020cited by 0position: middledoi
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial
BMC Cancer 2019cited by 36position: middledoi
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
BMC Cancer 2019cited by 1position: middledoi
Whole brain radiation therapy alone versus radiosurgery for patients with 1–10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial
Trials 2018cited by 32position: middledoi
Robotic Radiosurgery for Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence (CYBER-SPACE)—A Single-Center Prospective Randomized Trial
Neurosurgery 2018cited by 11position: middledoi
Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)—A Single-Center Prospective Randomized Trial
Neurosurgery 2018cited by 10position: middledoi
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer: The FORCE trial
Annals of Oncology 2018cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jürgen Debus · NYU Langone Health13 papers (2018–2022)Johannes Krisam · Boehringer Ingelheim (Germany)11 papers (2018–2022)Meinhard Kieser · Heidelberg University9 papers (2018–2022)Semi Harrabi · Heidelberg University6 papers (2020–2022)Klaus Herfarth · Universitätsklinik für Strahlentherapie5 papers (2020–2022)Stefan Rieken · University Medical Center5 papers (2018–2019)Kristin Lang · Heidelberg University4 papers (2018–2021)Farastuk Bozorgmehr · University Hospital Heidelberg4 papers (2018–2020)Laila König · Heidelberg University4 papers (2018–2021)Michael Thomas · Barwon Health4 papers (2018–2020)Rami A. El Shafie · University Medical Center3 papers (2018–2018)Thomas Welzel · Heidelberg University3 papers (2018–2018)C. Jaekel · Heidelberg University3 papers (2021–2022)Felix Lasitschka · Heidelberg University3 papers (2018–2020)Daniela Schmitt · University Medical Center3 papers (2018–2018)Christina Klose · Zimmer Biomet (Netherlands)3 papers (2018–2018) · 3 papers (2019–2020)Nathalie Arians · Heidelberg University3 papers (2020–2021)Juliane Hörner‐Rieber · German Cancer Research Center3 papers (2018–2021)Denise Bernhardt · TUM Klinikum3 papers (2018–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Radiation · Pulmonary and Respiratory Medicine →